RE:RE:RE:RE:RE:RE:RE:It would be greatWorking off of assumptions here (as we lack information) but I think the pilot plant will be dedicated to testing and producing new materials (ie. insulin, thin strips) while having enough capacity to produce AVAs and BG at current sales volumes.
What I think CZO is trying to do is to negotiate financing for a new commercial grade plant that will focus purely on pumping out BG-CoQ10 for the drink. Hoping that they can get enough up front payments to cover the plant without any dilution (but not holding my breath on this one). It's possible they want a US listing in the hopes of increasing the SP and then do another equity raise.
Again, lacking any credible information on the size of drink deal, the partner(s) etc. it's difficult to say for certain what the plan/strategy is and how it will be funded.